This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

How Health Care Stocks Are Faring

NEW YORK ( TheStreet) -- The Supreme Court will announce its decision on the constitutionality of Obamacare Thursday.

In case you don't remember, the real name of the bill is "Patient Protection and Affordable Care Act." From different surveys I have read, it appears there's a 75% chance that the individual health care mandate in the act will be ruled unconstitutional.

ValuEngine shows that the Medical Sector is 7.4% overvalued, but within that sector, the Health Maintenance Organizations Industry is 5.6% undervalued.

I will evaluate the price performance of nine stocks in this industry focusing on the volatility since March 26, when the Supreme Court began deliberating on Obamacare.

All nine of the stocks I profile are rated Strong Buy or Buy according to ValuEngine, and all but one traded lower during the period of deliberation by the Supreme Court. Those that have moved lower have been hurt by the general uncertainty about the outcome, and may have higher costs to adjust to the outcome.

Here's a table of information from www.ValuEngine.com include my value levels, pivots and risky levels.

Definitions of the Columns

OV/UN Valued: Red is the percent undervalued. Black is the percent overvalued. The most undervalued stock is Health Net (HNT - Get Report), at 23.5% undervalued. The most overvalued is Coventry Healthcare (CVH), at 14.6% overvalued.

VE Rating: 5-Engine is Strong Buy. 4-Engine is Buy. The Strong Buys are Aetna Inc (AET), UnitedHealth Group (UNH), Wellcare Health (WCG - Get Report) and Wellpoint Inc (WLP).

Last 12-Month Return (%): Red is negative. Black is positive. UNH is the only stock on the list to post a price rise over the past twelve months with a 17.8% gain.

Forecast One-Year Return: Since they are all rated Buy or better, the upside projection is in black. Those with a projected gain of 12% or more garner the 5-Engine, Strong Buy rating.

P/E Ratios: The price-to-earnings ratios range from 7.1 to 22.4.

Value Level: The price at which to enter a good 'til canceled limit order to buy on weakness (W-Weekly, M-Monthly, Q-Quarterly, S-Semiannual and A- Annual)

Pivot: A level between a value level and risky level that should be a magnet during the time frame noted.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
WLP $136.01 1.43%
HUM $181.18 0.00%
HNT $60.91 0.00%
WCG $92.33 0.00%
AAPL $125.80 -0.45%

Markets

DOW 17,976.31 +263.65 1.49%
S&P 500 2,086.24 +25.22 1.22%
NASDAQ 4,947.4410 +56.2220 1.15%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs